Patents by Inventor Lynne Jesaitis

Lynne Jesaitis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11262348
    Abstract: The present invention relates to cell-based methods for screening body fluids or tissues for factors that prevent cellular uptake of lysosomal enzymes, including neutralizing factors such as neutralizing antibodies, that arise as a result of lysosomal enzyme replacement therapy.
    Type: Grant
    Filed: November 7, 2016
    Date of Patent: March 1, 2022
    Assignee: BIOMARIN PHARMACEUTICAL INC.
    Inventors: Andrew Melton, Stephen Zoog, Lynne Jesaitis
  • Publication number: 20180321221
    Abstract: The present invention relates to cell-based methods for screening body fluids or tissues for factors that prevent cellular uptake of lysosomal enzymes, including neutralizing factors such as neutralizing antibodies, that arise as a result of lysosomal enzyme replacement therapy.
    Type: Application
    Filed: November 7, 2016
    Publication date: November 8, 2018
    Inventors: Andrew Melton, Stephen Zoog, Lynne Jesaitis
  • Publication number: 20050042623
    Abstract: Cell based methods designed to assess intracellular and extracellular activities and interactions and to identify compounds and conditions that modulate such activities and interactions are provided. The cell based methods employ capture systems that display collections of tagged molecules specifically linked to capture agents.
    Type: Application
    Filed: October 30, 2003
    Publication date: February 24, 2005
    Inventors: Dana Ault-Riche, Bruce Atkinson, Lynne Jesaitis, Krishnanand Kumble, Gizette Sperinde